论文部分内容阅读
目的 :探讨在治疗慢性阻塞性肺疾病合并肺间质纤维化中采用雾化吸入方法的效果。方法 :将我院2013年1月到2015年12月收治的100例慢性阻塞性肺病合并肺间质纤维化的患者进行分析,将这100例患者随机的分成观察组和对照组,每组50例,对照组的患者采用甲泼尼龙进行治疗,采用口服的方式治疗,观察组的患者在于雾化吸入的方式治疗,运用普米克令舒治疗,对两组患者的治疗效果进行对比。结果:在对两组的患者治疗后,观察组患者的治疗效果明显好于对照组,组间差异有统计学意义(P<0.05)。结论 :采用雾化吸入的方法治疗慢性阻塞性肺病合并肺间质纤维化,效果较好,值得在临床上应用。
Objective: To investigate the effect of using inhalation method in the treatment of pulmonary interstitial fibrosis in patients with chronic obstructive pulmonary disease. Methods: 100 patients with chronic obstructive pulmonary disease and pulmonary interstitial fibrosis who were treated in our hospital from January 2013 to December 2015 were analyzed. The 100 patients were randomly divided into observation group and control group, with 50 cases in each group For example, patients in the control group were treated with methylprednisolone and were treated orally. Patients in the observation group were treated with inhalation of nebulized inhalation. Pulmicort resveratrol was used to treat the patients in the two groups. Results: After the treatment of two groups of patients, the observation group patients treatment effect was significantly better than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: The treatment of chronic obstructive pulmonary disease with pulmonary interstitial fibrosis by the method of atomization inhalation is effective and worthy of clinical application.